Scholar Rock Holding (SRRK) EPS (Basic) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -23.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.88% |
| Dec 31, 2025 | -22.95% |
| Sep 30, 2025 | -36.36% |
| Jun 30, 2025 | -63.33% |
| Mar 31, 2025 | -13.56% |
| Dec 31, 2024 | -22.00% |
| Sep 30, 2024 | -24.53% |
| Jun 30, 2024 | -27.66% |
| Mar 31, 2024 | -20.41% |
| Dec 31, 2023 | -8.70% |
| Sep 30, 2023 | 3.64% |
| Jun 30, 2023 | 55.66% |
| Mar 31, 2023 | -133.33% |
| Dec 31, 2022 | 52.58% |
| Sep 30, 2022 | 46.08% |
| Jun 30, 2022 | -26.19% |
| Mar 31, 2022 | 72.37% |
| Dec 31, 2021 | -22.78% |
| Sep 30, 2021 | -29.11% |
| Jun 30, 2021 | -29.23% |
| Mar 31, 2021 | -31.03% |
| Dec 31, 2020 | -102.56% |
| Sep 30, 2020 | -43.64% |
| Jun 30, 2020 | -35.42% |
| Mar 31, 2020 | -38.10% |
| Dec 31, 2019 | 9.30% |
| Sep 30, 2019 | -25.00% |
| Jun 30, 2019 | 65.47% |
| Mar 31, 2019 | 86.79% |
| Dec 31, 2018 | 91.37% |
| Sep 30, 2018 | 88.11% |
| Jun 30, 2018 | 62.13% |